All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
KIROMIC BIOPHARMA, INC. Last Reported: 5/31/2024 Stock Symbol: KRBP

Business Address

7707 FANNIN ST.
SUITE 140
HOUSTON , TX US 77054

Mailing Address

7707 FANNIN ST.
SUITE 140
HOUSTON , TX US 77054
Phone Number: 832-968-4888 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 1/31/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 11/30/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 6/30/2018 5/31/2016
Cash and Cash Equivalents $3,204,000.00 $4,379,500.00 $2,704,200.00 $2,054,300.00 -- $645,200.00 $432,700.00 $6,510,600.00 $25,353,900.00 $35,161,800.00 $3,070,400.00 $10,150,500.00 $469,300.00 -- -- $1,929,100.00 -- -- -- -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- $16,200.00 $5,800.00 -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- $22,200.00 -- -- $22,200.00 -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $1,226,000.00 $1,558,200.00 $2,009,000.00 $1,462,400.00 -- $1,043,700.00 $1,705,500.00 $1,522,600.00 $1,699,400.00 $750,500.00 $875,600.00 $588,800.00 $1,051,900.00 -- -- $89,100.00 -- -- -- -- -- -- --
Total Current Assets $4,430,000.00 $5,937,700.00 $4,713,200.00 $3,516,700.00 -- $1,688,900.00 $2,138,200.00 $8,033,200.00 $27,069,500.00 $35,918,100.00 $3,946,000.00 $10,739,300.00 $1,543,400.00 -- -- $2,040,400.00 -- -- -- -- -- -- --
Property Plant and Equipement $6,175,100.00 $6,581,600.00 $7,061,800.00 $7,581,100.00 -- $8,136,900.00 $8,685,500.00 $9,157,700.00 $3,629,000.00 $2,578,800.00 $2,468,700.00 $2,066,000.00 $1,612,300.00 -- -- $587,900.00 -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- $41,800.00 -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- $386,000.00 -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $21,400.00 $21,400.00 $21,400.00 $24,400.00 -- $24,400.00 $31,100.00 $31,100.00 $31,100.00 $31,200.00 $24,400.00 $24,400.00 $24,400.00 -- -- $24,400.00 -- -- -- -- -- -- --
Total Assets $12,169,000.00 $14,233,500.00 $13,636,800.00 $13,108,000.00 -- $11,967,500.00 $13,019,300.00 $19,520,300.00 $30,729,600.00 $38,955,900.00 $6,439,100.00 $12,829,700.00 $3,180,100.00 -- -- $2,652,700.00 -- -- -- -- -- -- --
Accounts Payable $2,136,000.00 $4,247,100.00 $6,621,500.00 $8,151,800.00 -- $7,308,100.00 $6,494,100.00 $4,163,700.00 $2,214,300.00 $927,700.00 $1,124,100.00 $665,200.00 $1,672,900.00 -- -- $452,400.00 -- -- -- -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $21,289,800.00 $18,720,900.00 $19,931,600.00 $21,248,300.00 -- $17,742,200.00 $12,735,200.00 $7,739,100.00 $3,409,800.00 $1,444,800.00 $1,566,600.00 $1,467,600.00 $2,251,500.00 -- -- $673,700.00 -- -- -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-122,896,800.00 $-118,205,700.00 $-114,012,200.00 $-107,247,800.00 -- $-101,947,500.00 $-94,879,700.00 $-83,019,400.00 $-67,216,500.00 $-56,581,400.00 $-50,456,600.00 $-41,627,800.00 $-38,062,900.00 -- -- $-22,427,600.00 -- -- -- -- -- -- --
Total Stockholders' Equity $-9,120,800.00 $-4,487,400.00 $-6,294,800.00 $-8,140,300.00 -- $-5,774,700.00 $284,100.00 $11,781,200.00 $27,319,800.00 $37,511,100.00 $4,872,500.00 $11,362,100.00 $928,600.00 $2,095,300.00 $3,582,300.00 $1,979,000.00 -- $679,000.00 $-197,000.00 $-21,600.00 $265,300.00 -- --
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $12,169,000.00 $14,233,500.00 $13,636,800.00 $13,108,000.00 -- $11,967,500.00 $13,019,300.00 $19,520,300.00 $30,729,600.00 $38,955,900.00 $6,439,100.00 $12,829,700.00 $3,180,100.00 -- -- $2,652,700.00 -- -- -- -- -- -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 1/31/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 11/30/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 6/30/2018 5/31/2016
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $9,624,900.00 $2,677,200.00 $4,041,600.00 $2,075,000.00 -- $13,920,400.00 $3,784,200.00 $6,806,500.00 $11,367,800.00 $8,030,400.00 $4,543,700.00 $5,052,900.00 $3,526,100.00 -- -- $1,201,700.00 -- $601,500.00 -- -- -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $19,939,300.00 $14,621,600.00 $9,069,900.00 $4,777,400.00 -- $31,114,300.00 $8,395,900.00 $8,432,400.00 $25,735,700.00 $15,071,100.00 $8,928,800.00 $19,196,900.00 $15,635,300.00 -- -- $3,705,400.00 -- $1,535,800.00 -- -- -- -- --
Loss from Operations $-19,939,300.00 $-14,621,600.00 $-9,069,900.00 $-4,777,400.00 -- $-31,114,300.00 $-24,193,300.00 $-15,797,300.00 $-25,735,700.00 $-15,071,100.00 $-8,928,800.00 $-19,196,900.00 $-15,635,300.00 -- -- $-3,705,400.00 -- $-1,535,800.00 -- -- -- -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-12.59 $-8.43 $-8.07 $-6.17 -- $-64.42 $-1.78 $-0.54 $-2.26 $-1.50 -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 1,097,630 1,040,190 964,049 872,818 -- 544,475 15,706,079 15,637,777 11,417,083 15,366,075 -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-12.59 $-8.43 $-8.07 $-6.17 -- $-64.42 $-1.78 $-1.02 $-2.26 $-1.50 -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 1,097,630 1,040,190 964,049 872,818 -- 544,475 15,840,454 15,637,777 11,417,083 10,048,170 -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 300,000,000 300,000,000 300,000,000 300,000,000 -- 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 858,615 858,615 -- 300,000,000 -- 30,000,000 -- -- -- 858,615 --
Common Stock Shares Outstanding 1,258,460 1,176,260 1,176,260 979,243 -- 648,384 15,843,191 15,839,112 15,488,516 15,477,518 7,387,500 7,332,999 4,989,269 -- -- 2,863,812 -- -- -- -- -- -- --
Common Stock Value $1,258.00 $1,176.00 $1,176.00 $979.00 -- $648.00 $9,300.00 $9,300.00 $9,300.00 $9,300.00 $1,300.00 $1,200.00 -- -- -- -- -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- $0.00 -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 60,000,000 60,000,000 60,000,000 -- -- 60,000,000 60,000,000 60,000,000 60,000,000 60,000,000 60,000,000 60,000,000 60,000,000 -- -- 60,000,000 -- -- -- -- -- -- --
Preferred Stock Shares Outstanding 14,000 14,000 8,000 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value $2.00 $2.00 $1.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 -- -- $0.00 -- -- -- -- -- -- -- -- -- $0.00 $0.01 -- -- -- -- -- $0.00
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com